Clinical Trial Detail

NCT ID NCT03099486
Title Regorafenib Plus 5-Fluorouracil/Leucovorin Beyond Progression in mCRC
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fox Chase Cancer Center
Indications

colorectal cancer

Therapies

Fluorouracil + Leucovorin + Regorafenib

Age Groups: adult senior

No variant requirements are available.